Alpha(1)-Adrenergic Receptors Prevent A Maladaptive Cardiac Response To Pressure Overload
UTSePress Research/Manakin Repository
JavaScript is disabled for your browser. Some features of this site may not work without it.
- UTSePress Research Home
- >
- 11 Medical and Health Sciences
- >
- Journal Articles
- >
- Closed
- >
- View Item
| dc.contributor.author | O'Connell T | en_US |
| dc.contributor.author | Swigart Pm | en_US |
| dc.contributor.author | Rodrigo Mc | en_US |
| dc.contributor.author | Ishizaka S | en_US |
| dc.contributor.author | Joho S | en_US |
| dc.contributor.author | Turnbull Lynne | en_US |
| dc.contributor.author | Tecott Lh | en_US |
| dc.contributor.author | Baker Anthony | en_US |
| dc.contributor.author | Foster E | en_US |
| dc.contributor.author | Grossman W | en_US |
| dc.contributor.author | Simpson Pc | en_US |
| dc.contributor.editor | en_US | |
| dc.date.accessioned | 2010-05-28T09:50:55Z | |
| dc.date.available | 2010-05-28T09:50:55Z | |
| dc.date.issued | 2006 | en_US |
| dc.identifier | 2008006492 | en_US |
| dc.identifier.citation | O'Connell T et al. 2006, 'Alpha(1)-Adrenergic Receptors Prevent A Maladaptive Cardiac Response To Pressure Overload', Amer Soc Clinical Investigation Inc, vol. 116, no. 4, pp. 1005-1015. | en_US |
| dc.identifier.issn | 0021-9738 | en_US |
| dc.identifier.other | C1 | en_US |
| dc.identifier.uri | http://hdl.handle.net/10453/9639 | |
| dc.description.abstract | An alpha(1)-adrenergic receptor (alpha(1)-AR) antagonist increased heart failure in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), but it is unknown whether this adverse result was due to alpha(1)-AR inhibition | en_US |
| dc.language | en_US | |
| dc.publisher | Amer Soc Clinical Investigation Inc | en_US |
| dc.relation.isbasedon | http://dx.doi.org/10.1172/JCI22811 | en_US |
| dc.title | Alpha(1)-Adrenergic Receptors Prevent A Maladaptive Cardiac Response To Pressure Overload | en_US |
| dc.parent | Journal Of Clinical Investigation | en_US |
| dc.journal.volume | 116 | en_US |
| dc.journal.number | 4 | en_US |
| dc.publocation | Ann Arbor | en_US |
| dc.identifier.startpage | 1005 | en_US |
| dc.identifier.endpage | 1015 | en_US |
| dc.cauo.name | SCI.Institute for Biotechnology of Infectious Diseases | en_US |
| dc.conference | Verified OK | en_US |
| dc.for | 110300 | en_US |
| dc.personcode | 0000051973;0000051754;0000051755;0000051756;0000051757;0000051758;0000051759;0000051760;0000051761;0000051762;103744 | en_US |
| dc.percentage | 000100 | en_US |
| dc.classification.name | Clinical Sciences | en_US |
| dc.classification.type | FOR-08 | en_US |
| dc.edition | en_US | |
| dc.custom | en_US | |
| dc.date.activity | en_US | |
| dc.location.activity | ISI:000236556100022 | en_US |
| dc.description.keywords | NA | en_US |
| dc.staffid | University of California, San Francisco | en_US |
